mTOR Cancer Research Results

mTOR, mammalian target of rapamycin: Click to Expand ⟱
Source: HalifaxProj (inhibit)
Type:
mTOR (mechanistic target of rapamycin) is a central regulator of cell growth, proliferation, metabolism, and survival. It is a serine/threonine kinase that integrates signals from nutrients, growth factors, and cellular energy status.
mTOR promotes protein synthesis and cell growth by activating downstream targets such as S6 kinase and 4E-BP1. In cancer, this pathway can become hyperactivated, leading to uncontrolled cell proliferation.

mTor Inhibitors:
-rapamycin (Sirolimus): classic natural product mTOR inhibitor
-Curcumin
-Resveratrol
-Epigallocatechin Gallate (EGCG)
-Honokiol
Scientific Papers found: Click to Expand⟱
8150- lamb,    Reactive oxygen species dependent phosphorylation of the liver kinase B1/AMP activated protein kinase/ acetyl-CoA carboxylase signaling is critically involved in apoptotic effect of lambertianic acid in hepatocellular carcinoma cells
- in-vitro, HCC, HepG2 - in-vitro, HCC, SK-HEP-1
lipidLev↓, TumCCA↑, cl‑Casp3↑, cl‑PARP↑, AMPK↑, Akt↓, mTOR↓, Bcl-2↓, Bcl-xL↓, COX2/PTGS2↓, ROS↑, eff↓, p‑STK11/LKB1↑, p‑ACC↑, *Obesity↓, *Stress↓, *antiAll↑, tumCV↓, selectivity↑, TumCP↓, *antiAll↑,
8176- Las,    In Vitro and In Vivo Anti-Cancer Activity of Lasiokaurin in a Triple-Negative Breast Cancer Model
- vitro+vivo, BC, NA
TumCCA↑, Apoptosis↑, DNAdam↑, TumMeta↓, PI3K↓, Akt↓, mTOR↓, STAT3↓, TumVol↓, toxicity↓,
8178- Las,    Lasiokaurin suppresses breast cancer growth by blocking autophagic flux and regulating cellular energy homeostasis
- in-vitro, BC, NA
Akt↓, mTOR↓, PDK1 / PDPK1↓, ATP↓, TumCD↑,
8237- LCA,    Role of Licochalcone A in Potential Pharmacological Therapy: A Review
- Review, Var, NA
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
8208- LCA,    Licochalcone A inhibits PI3K/Akt/mTOR signaling pathway activation and promotes autophagy in breast cancer cells
- in-vitro, BC, MCF7
*Inflam↓, *AntiCan↑, *AntiP↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, Casp3↑, Bcl-2↓, TumAuto↑, Apoptosis↑, tumCV?,
8235- LCA,    Anticancer effects of licochalcones: A review of the mechanisms
- Review, Var, NA
mt-Apoptosis↑, TumAuto↑, TumCMig↓, LC3‑Ⅱ/LC3‑Ⅰ↑, ATG5↑, ATG7↑, p62↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, ATG3↑, Beclin-1/ATG6↑, ATG16L1↑, PERK↑, ATF4↑, ATP↓, Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, Bcl-xL↓, Bcl-2↓, BAD↑, BAX↑, Casp3↑, survivin↓, EGFR↓, ERK↓, Akt↓, mtDam↑, MMP↓, Cyt‑c↑, Casp↑, MDM2↓, CycB/CCNB1↓, CDC2↓, CDC25↓, TumCCA↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, Sp1/3/4↓, MMP-10↓, MMP3↓, TumCI↓, Imm↑, PD-L1↓, ROS↑, 4E-BP1↓, eIF2α↓, PI3K↓, mTOR↓, p‑cMET↑, Ca+2↑, RUBCN↓, ATG13↑, TSC1↑, TSC2↑, PRAS40↑, PP2A↑, ULK1/ATG1↑, THEM4/CTMP↑, DR5↑, Fas↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, PKCδ↓, P70S6K↓, VEGF↓, angioG↓, HK2↓, Glycolysis↓, TrxR1↓, APAF1↑, cl‑PARP↑, Bax:Bcl2↑, ABCG2↓, BioEnh↑,
8229- LCA,    Licochalcone A: a review of its pharmacology activities and molecular mechanisms
- Review, Nor, NA
*Inflam↓, *NO↓, *NF-kB↓, *TAC↑, Apoptosis?, TumCCA↑, TumCI↓, TumMeta↓, TumCP↓, MAPK↓, Akt↓, IL6↓, IL8↓, VEGFR2/KDR/Flk1↓, LC3II↑, PI3K↓, mTOR↓, mtDam↑, MMP↓, *NRF2↑, *PGE2↓, *Obesity↓, *SIRT1↑, *AMPK↑, *AntiFungal↑, *AntiP↑, *BMD↑, *GastroP↑,
8234- LCA,    Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
- Review, AD, NA
*neuroP↑, *PTP1B↓, *cognitive↑, *BDNF↑, *TrkB↝, *cJun↓, *p‑tau↓, *AChE↓, *Ach↑, *Aβ↓, *antiOx↑, *NRF2↑, *AntiViral↑, *Obesity↓, *PI3K↑, *Akt↑, *mTOR↑, *memory↑, *BBB↑,
8341- LDN,    Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
- Review, Var, NA
OGFr↑, TumCP↓, TumCCA↑, Apoptosis↑, toxicity↝, Half-Life↝, *FasL↓, *Fas↓, BAX↑, Casp9↑, Casp3↑, Bcl-2↓, survivin↓, PI3K↓, PDK1 / PDPK1↓, mTOR↓, ChemoSen↑, chemoP↑, Synergy↑, QoL∅,
8338- LDN,    Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway
- vitro+vivo, Cerv, HeLa - in-vitro, Cerv, SiHa
TumCP↓, TumCMig↓, TumCI↓, PI3K↓, p‑Akt↓, mTOR↓, OGFr↑, Dose↝, *toxicity↝, chemoP↑, ChemoSen↑,
8291- LE,    Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT/mTOR/STAT3 signaling
- vitro+vivo, AML, TF1
*Ingr↝, *AntiViral↑, *AntiCan↑, *Inflam↓, TumCMig↓, TumCI↓, Akt↓, mTOR↓, STAT3↓, Dose↝,
8236- LE,    Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
- Review, Var, NA
Bcl-2↓, CDK2↓, PI3K↓, cJun↓, mTOR↓, NF-kB↓, VEGF↓, MMP3↓, toxicity↓, Dose↑, chemoP↑, *antiOx↑, *Inflam↓, Dose↝, *COX2/PTGS2↓, *iNOS↓, *IL6↓, *IL10↓, *PGE2↓, *IκB?, *NRF2↑, *HO-1↑, *lipid-P↓, *ROS↓, *Catalase↑, *GPx↑, *SOD↑, Apoptosis↑, ROS↑, TumCP↓, TumCCA↑, cycE/CCNE↓, cycD1/CCND1↓, p‑GSK‐3β↓, PI3K↓, MKK4↓, MKK7↓, HSP90↓, LC3‑Ⅱ/LC3‑Ⅰ↑, Beclin-1/ATG6↑, p62↓, p‑Akt↓, cl‑Casp9↑, cl‑Casp7↑, cl‑Casp3↑, cl‑PARP↑, BAX↑, Cyt‑c↑, P53↑, STAT3↓, E-cadherin↑, Vim↓, N-cadherin↓, CD31/PECAM-1↓, Hif1a↓, iNOS↓, DNAdam↑, MMP↓, BIM↑, APAF1↑, PCNA↓, toxicity↝, eff↑,
8274- LE,    Research on the Antiaging Activity of Licorice Water Extract in Aging Mice via Antioxidation, Neuronal Protection, Gut Microbiota Restoration, and PI3K/AKT/mTOR Modulation
- in-vivo, Nor, NA
*AntiAge↑, *GutMicro↑, *p‑PI3K↓, *p‑Akt↓, *p‑mTOR↓, *antiOx?, *cognitive↑, *Dose↝, *GPx↑, *Catalase↑, *SOD↑, *MDA↓, *memory↑,
8278- LE,    Glycyrrhiza glabra (Licorice): A Comprehensive Review on Its Phytochemistry, Biological Activities, Clinical Evidence and Toxicology
- Review, Var, NA
*Ingr↝, *AntiCan↑, *AntiDiabetic↑, *AntiBio↑, *Inflam↓, *antiAll↑, *hepatoP↑, *cough?, *SoreThr?, *toxicity↝, *cardioP↑, *BioAv↝, *PGE2↓, *COX2/PTGS2↓, *AntiAg↑, *ROS↓, *NLRP3↓, *NF-kB↓, *AP-1↓, TumCCA↑, Apoptosis↑, TumMeta↑, *Dose↝, *Dose↝, Ingr↝, TumAuto↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, *cognitive↑, *BloodF↑, ChemoSen↑, ROS↓, *chemoP↑, ROS↑, tumCV↓, MMP↓, *AntiBio↑, *toxicity↝,
8131- LF,    Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma
- in-vitro, OS, HSC2 - in-vitro, OS, HSC3 - in-vitro, OS, HSC4 - in-vitro, Nor, RT7
P53↑, Akt↓, SOCS-3↑, mTOR↓, JAK↓, STAT3↓, selectivity↑, TumCP↓, Iron↓, TumCCA↑,
8317- LIN,    Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways
- in-vitro, Liver, HepG2
TumCP↓, TumCCA↑, CDK4↓, cycA1/CCNA1↓, P21↑, p27/CDKN1B↑, Apoptosis↑, MMP↓, Casp3↑, cl‑PARP↑, DNAdam↑, RAS↓, Akt↓, mTOR↓, ROS↑, MAPK↑,
8377- LT,    Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
- Review, Asthma, NA
*PI3K↑, *Akt↑, *Inflam↓, *ROS↓, *BioAv↓, *RenoP↑, *cardioP↑, *neuroP↑, *antiAll↑, *AntiDiabetic↑, *hepatoP↑, *AntiThr↑, *toxicity↓, *IL10↓, *Sepsis↓, *TNF-α↓, *ROS↓, *GSH↑, *Catalase↑, *SOD↑, *MDA↓, *lipid-P↓, *IL4↓, *IL5↓, *PGE2↓, *PI3K↑, *Akt↑, *mTOR↑, *Beclin-1/ATG6↓, *Mucositis↓, *PLA2↓, STAT3↓, PD-L1↓, miR-34a↓, Casp3↑, Casp9↑, Bcl-2↓, BAX↑, Bax:Bcl2↑, Apoptosis↑, ROS↑, EMT↓, E-cadherin↓, DR5↑, LIMK1↓, Pain↓,
8384- LT,    Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors
- Review, GC, NA
Apoptosis↑, TumAuto↑, TumCCA↑, EMT↓, *ROS↓, *antiOx↑, ROS↑, P53↑, LC3II↑, Beclin-1/ATG6↑, p‑MAP2K1/MEK1↓, p‑ERK↓, BAX↑, cl‑Casp3↑, Bcl-2↓, p‑MAPK↓, DNArepair↓, HMGB1↓, XRCC1↓, ERCC3↑, CycB/CCNB1↓, CDC2↓, p‑CHK1↑, TumCCA↑, TumCP?, Wnt↓, β-catenin/ZEB1↓, miR-384↑, PTN↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, Ferroptosis↑, GPx4↓, Synergy↑, Ki-67↓, GSH↓, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, NF-kB↓, NOTCH↓, miR-139-5p↑, miR-34a↑, miR-422a↑, miR-107↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, E-cadherin↑, N-cadherin↓, Vim↓, HK1↓, FOXO1↓, compI↓, compIII↓, compV↓, ETC↓, BioAv↝,
8390- LT,    Luteolin in Inflammatory Bowel Disease and Colorectal Cancer: A Disease Continuum Perspective
- Review, IBD, NA - Review, CRC, NA
*Diff↝, *Inflam↓, *ROS↓, *GutMicro↑, *IBI↑, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, *BioAv↑, *iNOS↓, *TNF-α↓, *IL6↓, *MDA↓, *lipid-P↓, *antiOx↑, *NRF2↑, *HO-1↑, *NQO1↑, *SOD↑, *Catalase↑, *5HT↓, *TPH1↓, *MAPK↓, *ERK↓, *Inflam↓, cycD1/CCND1↓, CDK4↓, TumCCA↑, Casp3↑, Casp9↑, PI3K↓, Akt↓, p‑Akt↓, p‑mTOR↓, E-cadherin↑, N-cadherin↓, Vim↓,
8402- LT,    Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
- vitro+vivo, CRC, T24/HTB-9
tumCV↓, TumCCA↑, p‑S6↓, P21↑, Trx1↑, ROS↓, Ki-67↓, mTOR↓, TumCP↓,
8397- LT,    Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules
- Review, Var, NA
tumCV↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, mTOR↓, PI3K↓, Akt↓, STAT3↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, Apoptosis↑, hTERT/TERT↓, AP-1↓, NF-kB↓, MAPK↓, HSP90↓, AR↓, IGF-1R↓, Akt↓, NOTCH↓, IL6↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, TumVol∅, TumW∅, miR-34a↑, miR-107↑, miR-139-5p↑, miR-422a↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, *toxicity↓,
8369- LT,    Luteolin inhibits proliferation of lung cancer A549 cells by increasing ROS production and inhibiting the AKT/mTOR signaling pathway and HO-1 expression
- in-vitro, Lung, A549
tumCV↓, TumCP↓, ROS↑, BAX↑, cl‑Casp9↑, Beclin-1/ATG6↑, LC3B-II↑, Bcl-2↓, p62↓, TumAuto↑, p‑Akt↓, p‑mTOR↓, HO-1↓,
2919- LT,    Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence
- Review, Var, NA
RadioS↑, ChemoSen↑, chemoP↑, *lipid-P↓, *Catalase↑, *SOD↑, *GPx↑, *GSTs↑, *GSH↑, *TNF-α↓, *IL1β↓, *Casp3↓, *IL10↑, NRF2↓, HO-1↓, NQO1↓, GSH↓, MET↓, p‑MET↓, p‑Akt↓, HGF/c-Met↓, NF-kB↓, Bcl-2↓, SOD2↓, Casp8↑, Casp3↑, PARP↑, MAPK↓, NLRP3↓, ASC↓, Casp1↓, IL6↓, IKKα↓, p‑p65↓, p‑p38↑, MMP2↓, ICAM-1↓, EGFR↑, p‑PI3K↓, E-cadherin↓, ZO-1↑, N-cadherin↓, CLDN1↓, β-catenin/ZEB1↓, Snail↓, Vim↑, ITGB1↓, FAK↓, p‑Src↓, Rac1↓, Cdc42↓, Rho↓, PCNA↓, Tyro3↓, AXL↓, CEA↓, NSE↓, SOD↓, Catalase↓, GPx↓, GSR↓, GSTs↓, GSH↓, VitE↓, VitC↓, CYP1A1↓, cFos↑, AR↓, AIF↑, p‑STAT6↓, p‑MDM2↓, NOTCH1↓, VEGF↓, H3↓, H4↓, HDAC↓, SIRT1↓, ROS↑, DR5↑, Cyt‑c↑, p‑JNK↑, PTEN↓, mTOR↓, CD34↓, FasL↑, Fas↑, XIAP↓, p‑eIF2α↑, CHOP/DDIT3↑, LC3II↑, PD-1↓, STAT3↓, IL2↑, EMT↓, cachexia↓, BioAv↑, *Half-Life↝, *eff↑,
2916- LT,    Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies
- Review, Var, NA - Review, AD, NA - Review, Park, NA
proCasp9↓, CDC2↓, CycB/CCNB1↓, Casp9↑, Casp3↑, Cyt‑c↑, cycA1/CCNA1↑, CDK2↓, APAF1↑, TumCCA↑, P53↑, BAX↑, VEGF↓, Bcl-2↓, Apoptosis↑, p‑Akt↓, p‑EGFR↓, p‑ERK↓, p‑STAT3↓, cardioP↑, Catalase↓, SOD↓, *BioAv↓, *antiOx↑, *ROS↓, *NO↓, *GSTs↑, *GSR↑, *SOD↑, *Catalase↑, *lipid-P↓, PI3K↓, Akt↓, CDK2↓, BNIP3↑, hTERT/TERT↓, DR5↑, Beclin-1/ATG6↑, TNF-α↓, NF-kB↓, IL1↓, IL6↓, EMT↓, FAK↓, E-cadherin↑, MDM2↓, NOTCH↓, MAPK↑, Vim↓, N-cadherin↓, Snail↓, MMP2↓, Twist↓, MMP9↓, ROS↑, MMP↓, *AChE↓, *MMP↑, *Aβ↓, *neuroP↑, Trx1↑, ROS↓, *NRF2↑, NRF2↓, *BBB↑, ChemoSen↑, GutMicro↑, *antiAll↑, *Mucositis↓, *TregCell↑, *Beclin-1/ATG6↓, *PI3K↑, *Akt↑, *mTOR↑,
4293- LT,    Regulatory Role of NF-κB on HDAC2 and Tau Hyperphosphorylation in Diabetic Encephalopathy and the Therapeutic Potential of Luteolin
- in-vivo, Diabetic, NA
*Inflam↓, *antiOx↑, *neuroP↑, *cognitive↑, *p‑mTOR↓, *p‑NF-kB↓, *HDAC2↓, *BDNF↑, *other↓, *p‑tau↓,
3265- Lyco,    Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway
- in-vitro, Nor, NA
*AMPK↑, *mTOR↓, *NLRP3↓, *Pyro↓,
3275- Lyco,    Multifaceted Effects of Lycopene: A Boulevard to the Multitarget-Based Treatment for Cancer
- Review, Var, NA
TumCCA↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, P21↑, P53↑, GSK‐3β↓, p27/CDKN1B↓, Akt↓, mTOR↓, ROS↓, MMPs↓, TumCI↓, TumCMig↓, NF-kB↓, *iNOS↓, *COX2/PTGS2↓, lipid-P↓, GSH↑, NRF2↑,
4800- Lyco,    Recent insights on pharmacological potential of lycopene and its nanoformulations: an emerging paradigm towards improvement of human health
- Review, Var, NA
*antiOx↑, Keap1↝, NF-kB↝, NRF2↝, PI3K↝, Akt↝, mTOR↝, *GutMicro↑,
4786- Lyco,    Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines
- in-vitro, BC, MDA-MB-468 - in-vitro, BC, MCF7 - in-vitro, BC, SkBr3
TumCP↓, TumCCA↑, cl‑PARP↑, ERK↑, cycD1/CCND1↓, P21↓, p‑Akt↓, mTOR↓, BAX↑, AntiCan↑, Risk↓,
4791- Lyco,    Investigating into anti-cancer potential of lycopene: Molecular targets
- Review, Var, NA
*antiOx↑, TumCP↓, TumCCA↓, Apoptosis↑, TumCI↓, angioG↓, TumMeta↓, *Risk↓, cycD1/CCND1↓, CycD3↓, cycE/CCNE↓, CDK2↓, CDK4↓, Bcl-2↓, P21↑, p27/CDKN1B↑, P53↑, BAX↑, selectivity↑, MMP↓, Cyt‑c↑, Wnt↓, Synergy↑, PPARγ↑, LDL↓, Akt↓, PI3K↓, mTOR↓, PDGF↓, NF-kB↓, ChemoSen↑,
1126- Lyco,    Lycopene Inhibits Epithelial–Mesenchymal Transition and Promotes Apoptosis in Oral Cancer via PI3K/AKT/m-TOR Signal Pathway
- vitro+vivo, Oral, NA
TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, EMT↓, PI3K↓, Akt↓, mTOR↓, E-cadherin↓, BAX↑, N-cadherin↓, p‑PI3K↓, p‑Akt↓, p‑mTOR↓, Bcl-2↓,
2540- M-Blu,    Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots
- Review, Var, NA - Review, AD, NA
*OCR↑, *Glycolysis↓, *GlucoseCon↑, neuroP↑, Warburg↓, mt-OXPHOS↑, TumCCA↑, TumCP↓, ROS⇅, *cognitive↑, *mTOR↓, *mt-antiOx↑, *memory↑, *BBB↑, *eff↝, *ECAR↓, eff↑, lactateProd↓, NADPH↓, OXPHOS↑, AMPK↑, selectivity↑,
972- MAG,    Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
- vitro+vivo, Bladder, T24/HTB-9
angioG↓, VEGF↓, H2O2↓, Hif1a↓, VEGFR2/KDR/Flk1↓, Akt↓, mTOR↓, P70S6K↓, 4E-BP1↓, TumCG↓, CD31/PECAM-1↓, CA↓,
8492- MAG,    Magnolol improves Alzheimer's disease-like pathologies and cognitive decline by promoting autophagy through activation of the AMPK/mTOR/ULK1 pathway
- in-vivo, AD, NA
*Apoptosis↑, *cl‑Casp9↓, *BAX↓, *Bcl-2↓, *p62↓, *LC3II↑, *Beclin-1/ATG6↑, *AMPK↑, *mTOR↑, *ULK1/ATG1↑,
4514- MAG,    Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
- Review, Var, NA
AntiCan↑, TumCP↓, TumCCA↑, TumMeta↓, angioG↓, NF-kB↓, MAPK↓, PI3K↓, Akt↓, mTOR↓, BioAv↓, *antiOx↑, *Inflam↓, *AntiAg↑, ChemoSen↑, cycD1/CCND1↓, CycB/CCNB1↓, cycE/CCNE↓, CDK2↓, CDK4↓, p27/CDKN1B↑, P21↑, P53↑, PTEN↓, XIAP↓, Mcl-1↓, Casp3↑, Casp9↑, MMP9↑,
4515- MAG,    Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight
- Review, Var, NA
AntiCan↑, TumCP↓, TumCCA↑, Apoptosis↑, TumCMig↑, angioG↓, PI3K↓, Akt↓, mTOR↓, MAPK↓, NF-kB↓,
4535- MAG,  5-FU,    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways
- in-vitro, Cerv, NA
ChemoSen↑, TumCP↓, vinculin↓, TumCA↓, TumCMig↓, TumCI↓, p‑Akt↓, p‑PI3K↓, mTOR↓, E-cadherin↑, β-catenin/ZEB1↑, Snail↓, Slug↓,
4528- MAG,    Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
- Review, Nor, NA
*Inflam↑, *cardioP↑, *angioG↓, *antiOx↑, *neuroP↑, *Bacteria↓, AntiTum↑, TumCG↓, TumCMig↓, TumCI↓, Apoptosis↑, E-cadherin↑, NF-kB↓, TumCCA↑, cycD1/CCND1↓, PCNA↓, Ki-67↓, MMP2↓, MMP7↓, MMP9↓, TumCG↓, Casp3↑, NF-kB↓, Akt↓, mTOR↓, LDH↓, Ca+2↑, Synergy↑, *toxicity↓, *BioAv↝, *PGE2↓, *TLR2↓, *TLR4↓, *MAPK↓, *PPARγ↓,
8564- Matr,    Matrine inhibits proliferation and promotes autophagy and apoptosis in non-small cell lung cancer cells by deactivating PI3K/AKT/mTOR pathway
- in-vitro, Lung, A549
TumCP↓, p‑Akt↓, p‑mTOR↓, LC3B↑, PI3K↓, Akt↓, mTOR↓,
8565- Matr,    Matrine induces apoptosis in acute myeloid leukemia cells by inhibiting the PI3K/Akt/mTOR signaling pathway
- in-vitro, AML, THP1
tumCV↓, p‑PI3K↓, p‑Akt↓, p‑mTOR↓,
8533- Matr,    Matrine induces the apoptosis of lung cancer cells through downregulation of inhibitor of apoptosis proteins and the Akt signaling pathway
- in-vitro, Lung, A549 - in-vitro, Lung, 95D
TumCP?, Apoptosis?, PI3K↓, Akt↓, mTOR↓, IAP1↓,
8526- Matr,    A Systematic Review of the Pharmacology, Toxicology and Pharmacokinetics of Matrine
- Review, Nor, NA
*AntiCan↑, *Inflam↓, *antiOx↑, *AntiViral↑, *Bacteria↓, *antiAll↑, *Analgesic↑, *hepatoP↑, *cardioP↑, *neuroP↑, *toxicity↝, p38↓, IL6↓, JAK2↓, STAT3↓, Casp↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, PCNA↓, Bcl-2↓, XIAP↑, VEGF↓, NF-kB↓, MMP2↓, MMP9↓, P-gp/ABCB1↓, survivin↓, OCT4↓, SOX2↓, p62↓, *TNF-α↓, *IL6↓, *HMGB1↓, *AntiArt↑, *NF-kB↓, *IL6↓, *IL8↓, *IL1β↓, *IL17↓, *TNF-α↓, *ROS↓, *NRF2?, *AST↓, *ALAT↓, *TGF-β↓, *α-SMA↓, *JAK2↑, *STAT3↑, *BioAv↝, *Half-Life↝, ChemoSen↑, ATP↓, ROS↑,
8544- Matr,    Matrine in Liver Diseases: Mechanistic Insights and Therapeutic Potential
- Review, BC, NA
*hepatoP↑, *Inflam↓, *ROS↓, *ER Stress↓, *lipid-P↓, TumCP↓, TumCI↓, TumCMig↓, TumAuto↑, Apoptosis↑, *AST↓, *ALAT↓, *SOD↑, *MDA↓, *TNF-α↓, *IL6↓, *NRF2↑, *HO-1?, *NF-kB↓, *Inflam↓, AFP?, PCNA↓, cMyc↓, Bcl-2↓, BAX↑, EMT↓, MDM2↓, P53↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, NOTCH↑, ChemoSen↑, eff↑, survivin↓, XIAP↓, Synergy↑,
8558- Matr,    Matrine exerts anti‑breast cancer activity by mediating apoptosis and protective autophagy via the AKT/mTOR pathway in MCF‑7 cells
- in-vitro, BC, MCF7
TumCG↓, TumAuto↑, LC3B-II↑, p62↓, Akt↓, mTOR↓,
8555- Matr,    Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
- Review, Var, NA
*AntiTum↑, *Inflam↓, *Analgesic↑, *AntiViral↑, *Imm↑, *PI3K↑, *Akt↑, *mTOR↑, TumAuto↑, PI3K↓, Akt↓, mTOR↓, Beclin-1/ATG6↑, E-cadherin↑, Vim↓, MMP2↓, MMP9↓, Snail↓, Slug↓, PTEN↑, TumCP↓, TumCMig↓, TumCI↓, ChemoSen↑, ROS↑, uPA↓, p‑ERK↓, cachexia↓, antiD↑, GSK‐3β↓, LC3B-II↑, p62↓, Apoptosis↑, Casp3↑, Casp8↑, Casp9↑, FOXO1↑, FOXO3↑, FOXO4↑, PARP↑, BIM↑, Bcl-2↓, survivin↓, miR-21↓, *HOTAIR↑, *p‑Akt↑, *p‑STAT3↑, *STAT3↑, *ROS↓, Wnt↓, β-catenin/ZEB1↓, NOTCH1↓, JAG1↓, HES1↓, BioAv↝, toxicity↝,
8553- Matr,    Research progress on the pharmacological effects of matrine
- Review, Nor, NA
*AntiCan↑, *antiAll↑, *Stroke↓, TumCI↓, TumCMig↓, TumCP↓, TumCCA↑, *AGEs↓, *Inflam↓, *antiOx↑, *neuroP↑, *Apoptosis↓, *IBI↑, *GutMicro↑, EGFR↓, *HSP60/HSPD1↓, *antiOx↑, *GSH↑, *Catalase↑, *AChE↓, *BChE↓, *neuroP↑, *PI3K↑, *Akt↑, *mTOR↑, *cognitive↑, *ROS↓, *toxicity↑,
8547- Matr,    Matrine in cancer therapy: antitumor mechanisms and nano-delivery strategies
- Review, Var, NA
*Ingr↝, *AntiTum↑, Apoptosis↑, TumAuto↑, Ferroptosis↑, TumCP↓, TumCMig↓, TumCI↓, JPT1/HN1↓, Erlin1↑, LINC01116↓, miR-592↑, ERK↓, JAK↓, STAT3↓, miR-182-5p↓, PI3K↓, Akt↓, Wnt↓, β-catenin/ZEB1↓, Sharpin↓, ROS↓, AMPK↑, mTOR↓, Snail↓, Vim↓, N-cadherin↓, MMP2↓, MMP9↓, E-cadherin↑, PTEN↑, miR-10b-5p↓, GPx4↓, lipid-P↑, Iron↑, Piezo1↑,
7824- MBS,  IVT,  VT,    Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review
- Review, AD, NA - Review, Stroke, NA - Review, Park, NA
*neuroP↑, *Aβ↓, *p‑tau↓, *ROS↓, *Inflam↓, *AChE↓, *BBB↑, *memory↑, *hepatoP↑, *Imm↑, *hyperG↓, *AntiCan↑, *eff↑, *Stroke↓, *BACE/β-secretase↓, *PI3K↓, *Akt↓, *mTOR↓, *Dose↓,
8620- MCT,    Medium-Chain Triglycerides: Scientific and Regulatory Perspectives from Germany and Japan with a US Context—A Concise Review
- Review, Nor, NA
*BioAv↑, *toxicity↓, *Obesity↓, *Akt↑, *mTOR↑, *Synergy↑, *cognitive↑, *Obesity↓,
2643- MCT,    Medium Chain Triglycerides enhances exercise endurance through the increased mitochondrial biogenesis and metabolism
- Review, Nor, NA
*Akt↑, *AMPK↓, *TGF-β↓, eff↑, *BioEnh↑, *ATP↑, *PGC-1α↑, *p‑mTOR↑, *SMAD3↓,

Showing Research Papers: 301 to 350 of 489
Prev Page 7 of 10 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 489

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 7,   ARE↑, 1,   Catalase↓, 7,   Catalase↑, 3,   Copper↓, 1,   Copper↑, 1,   Fenton↑, 3,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 9,   GSH↓, 23,   GSH↑, 6,   GSR↓, 2,   GSTs↓, 2,   GSTs↑, 3,   H2O2↓, 1,   H2O2↑, 6,   HO-1↓, 8,   HO-1↑, 19,   hyperG↓, 1,   Iron↓, 2,   Iron↑, 9,   i-Iron↓, 1,   i-Iron↑, 1,   c-Iron↑, 1,   Keap1↓, 1,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 6,   lipid-P↑, 12,   MDA↓, 4,   MDA↑, 11,   MPO↓, 1,   NADH↓, 1,   NADPH/NADP+↓, 1,   NOX4↑, 1,   NQO1↓, 3,   NQO1↑, 3,   NRF2↓, 22,   NRF2↑, 23,   NRF2↝, 3,   p‑NRF2↓, 1,   Prx4↑, 1,   PYCR1↓, 2,   ROS↓, 34,   ROS↑, 214,   ROS⇅, 8,   ROS↝, 3,   i-ROS↑, 1,   mt-ROS↑, 3,   SOD?, 1,   SOD↓, 9,   SOD↑, 8,   mt-SOD↑, 1,   SOD1↑, 2,   SOD2↓, 3,   SOD2↑, 2,   TAC↓, 2,   TBARS↑, 1,   Thiols↓, 1,   TKT↝, 1,   Trx↑, 1,   Trx1↑, 2,   TrxR↓, 8,   TrxR↑, 1,   TrxR1↓, 3,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 3,   FTH1↓, 2,   NCOA4↑, 2,   STEAP3↓, 1,   Tf↓, 1,   Tf↑, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 8,   CDC25↓, 13,   compI↓, 5,   compIII↓, 3,   compV↓, 1,   EGF↓, 5,   EGF↑, 1,   ETC↓, 4,   ETC↑, 1,   HSP60/HSPD1↓, 1,   Insulin↓, 1,   MCU↓, 1,   MFN2↑, 1,   mitResp↓, 7,   MKK7↓, 1,   mtDam↓, 1,   mtDam↑, 18,   OCR↓, 9,   OCR↑, 4,   OXPHOS↓, 6,   OXPHOS↑, 7,   OXPHOS↝, 1,   mt-OXPHOS↑, 1,   PDH↑, 3,   PGC-1α↑, 1,   PINK1↑, 3,   SIRT3↓, 1,   SIRT3↑, 4,   VDAC1↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 4,   AApath↓, 1,   ACC↓, 1,   ACC↑, 4,   p‑ACC↑, 1,   p‑ACC-α↑, 1,   ACC1↓, 1,   Acetyl-CoA↓, 1,   ACLY↓, 4,   ACSL4↑, 1,   adiP↑, 1,   ALAT↓, 2,   ALDOA↓, 1,   AMP↓, 2,   AMPK↓, 4,   AMPK↑, 62,   AMPK↝, 1,   p‑AMPK↑, 10,   ATGL/PNPLA2↓, 1,   ATP↓, 26,   ATP↑, 1,   mt-ATP↓, 2,   CAIX/CA9↓, 2,   CRM↑, 1,   ECAR↓, 5,   ENO1↓, 2,   FABP4↑, 1,   FASN↓, 6,   FASN↑, 1,   FBPase↑, 1,   FDG↓, 1,   FFA/NEFA↓, 1,   G6PD↓, 2,   GAPDH↓, 1,   GLO-I↓, 1,   GLS↓, 2,   glucoNG↑, 1,   glucose↓, 4,   GlucoseCon↓, 20,   GlutMet↓, 2,   glyC↓, 1,   Glycolysis↓, 50,   Glycolysis↝, 1,   p‑GS3Kβ↓, 1,   GSK‐3β↓, 16,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 4,   p‑GSK‐3β↑, 1,   HK1↓, 1,   HK2↓, 21,   HMG-CoA↓, 1,   HSL/LIPE↓, 1,   p‑HSL/LIPE↑, 1,   lactateProd↓, 21,   lactateProd↑, 1,   LDHA↓, 11,   LDL↓, 2,   lipidLev↓, 1,   lipoGen↓, 1,   MCT4↓, 1,   NAD↓, 1,   NAD↑, 1,   NADH:NAD↓, 2,   NADPH↓, 3,   NPC1L1↓, 1,   PDK1 / PDPK1↓, 13,   PDK3↑, 1,   PDKs↓, 1,   PFK↓, 4,   PFK1↓, 3,   PFK2↓, 1,   PFKFB3↓, 2,   PFKP↓, 1,   PKM2↓, 28,   PKM2↑, 1,   PKM2:PKM1↓, 1,   Pyruv↓, 1,   R5P↝, 1,   p‑S6↓, 3,   SCD1↓, 2,   SCP2↓, 1,   SIRT1↓, 5,   SIRT1↑, 10,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA↓, 1,   TCA↑, 3,   TumCM/A↓, 1,   Warburg↓, 18,  

Cell Death(tgid=5) ⓘ

AIF↑, 8,   APAF1↑, 11,   Apoptosis?, 3,   Apoptosis↓, 1,   Apoptosis↑, 193,   Apoptosis↝, 1,   mt-Apoptosis↑, 2,   ASC↓, 1,   ASC↑, 1,   ASK1↑, 2,   BAD?, 1,   BAD↓, 3,   BAD↑, 11,   Bak↑, 7,   BAX↓, 1,   BAX↑, 104,   BAX↝, 1,   Bax:Bcl2↑, 18,   Bcl-2↓, 112,   Bcl-2↑, 3,   Bcl-2↝, 1,   cl‑Bcl-2↓, 1,   Bcl-xL↓, 25,   Bcl-xL↑, 2,   Bcl-xL↝, 1,   BID↓, 1,   BID↑, 2,   BIM↓, 1,   BIM↑, 9,   BNIP3↑, 3,   BOK↑, 1,   Casp↓, 1,   Casp↑, 33,   Casp1↓, 2,   Casp1↑, 1,   Casp10↑, 2,   Casp2↑, 1,   Casp3↓, 5,   Casp3↑, 114,   Casp3↝, 1,   cl‑Casp3↓, 1,   cl‑Casp3↑, 26,   cl‑Casp3⇅, 1,   proCasp3↓, 2,   Casp6↓, 1,   Casp7↑, 10,   cl‑Casp7↑, 4,   Casp8↓, 1,   Casp8↑, 26,   Casp8∅, 1,   cl‑Casp8↑, 3,   proCasp8↑, 1,   pro‑Casp8↑, 1,   Casp9↓, 1,   Casp9↑, 66,   cl‑Casp9↓, 1,   cl‑Casp9↑, 11,   proCasp9↓, 1,   CellShr↑, 1,   cFLIP↓, 8,   Cyt‑c↓, 1,   Cyt‑c↑, 67,   Cyt‑c↝, 1,   Diablo↑, 9,   DR5↓, 1,   DR5↑, 22,   FADD↑, 5,   Fap1↓, 1,   Fas↓, 2,   Fas↑, 15,   FasL↑, 10,   Ferroptosis↑, 18,   GRP58↓, 1,   GSDMD↑, 1,   GSDME↑, 1,   IAP1↓, 8,   IAP2/BIRC3↓, 4,   IAP2/BIRC3↑, 1,   ICAD↓, 1,   ICD↑, 4,   iNOS↓, 12,   Mcl-1↓, 24,   MDM2↓, 10,   MDM2↑, 1,   p‑MDM2↓, 1,   MOMP↑, 3,   NAIP↓, 1,   Necroptosis↑, 1,   necrosis↑, 5,   oncosis↑, 2,   p38↓, 7,   p38↑, 17,   p‑p38↑, 4,   PUMA↓, 2,   PUMA↑, 3,   Pyro↑, 3,   RIP3↓, 1,   RIP3↑, 1,   survivin↓, 47,   TNFR 1↑, 2,   TRAIL↑, 6,   TRAILR↑, 2,   TumCD↓, 1,   TumCD↑, 13,   XIAP↓, 22,   XIAP↑, 1,   YAP/TEAD↓, 5,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 260,   Akt↑, 10,   Akt↝, 2,   p‑Akt↓, 75,   AKT1↓, 3,   AMPKα↑, 5,   CaMKII ↓, 2,   CaMKII ↑, 1,   CK2↓, 1,   cMET↓, 3,   p‑cMET↑, 2,   cSrc↓, 2,   EGFR↓, 47,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 1,   ERK↓, 36,   ERK↑, 9,   ERK↝, 1,   p‑ERK↓, 8,   p‑ERK↑, 3,   FGFR1↓, 2,   GNAI1↓, 1,   HER2/EBBR2↓, 12,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 1,   Hippo↓, 1,   IGF-1R↓, 3,   IKKα↓, 7,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB↓, 1,   IκB↑, 2,   p‑IκB↓, 1,   JAK↓, 7,   JAK1↓, 4,   JAK2↓, 15,   p‑JAK2↓, 1,   JNK↓, 3,   JNK↑, 15,   JNK↝, 1,   p‑JNK↑, 4,   LIMK1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 31,   MAPK↑, 13,   MAPK↝, 3,   p‑MAPK↓, 2,   p‑MAPK↑, 1,   MARK4↓, 1,   MEK↓, 7,   MEK↑, 1,   MKK4↓, 1,   MKP1↓, 1,   MKP2↓, 1,   mTOR?, 1,   mTOR↓, 353,   mTOR↑, 16,   mTOR⇅, 1,   mTOR↝, 4,   mTOR∅, 1,   p‑mTOR↓, 61,   p‑mTOR↑, 2,   mTORC2↓, 3,   mTORC2↑, 1,   p70S6↓, 5,   p70S6↑, 1,   p‑p70S6↓, 2,   P70S6K↓, 17,   P70S6K↑, 1,   p‑P70S6K↓, 7,   p‑P70S6K↑, 1,   p85S6K↓, 1,   p‑P90RSK↑, 1,   PDE3B↓, 1,   PI3K?, 1,   PI3K↓, 192,   PI3K↑, 5,   PI3K↝, 3,   p‑PI3K↓, 13,   PI3K/Akt↓, 5,   PI3k/Akt/mTOR↓, 4,   PIK3CA↓, 1,   PKA↓, 1,   p‑PKA↓, 1,   PKCδ↓, 5,   PP2A↑, 2,   PRAS40↑, 1,   PRKCG↑, 1,   PTEN↓, 5,   PTEN↑, 31,   PTEN↝, 1,   Raf↓, 3,   e-Raf↓, 1,   RAS↓, 13,   RAS↑, 1,   Rictor↓, 1,   RIP1↓, 2,   RIP1↑, 1,   RPS6KA1↓, 1,   S6K↓, 1,   p‑S6K↓, 2,   Sp1/3/4↓, 8,   Src↓, 2,   p‑Src↓, 2,   STAT↓, 6,   STAT3↓, 79,   STAT3↑, 2,   STAT3↝, 1,   p‑STAT3↓, 9,   p‑STAT3↑, 1,   STAT6↓, 3,   p‑STAT6↓, 1,   p‑STK11/LKB1↑, 2,   THEM4/CTMP↑, 1,   TSC2↑, 5,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF3↑, 1,   ATF4↓, 1,   ATF4↑, 10,   ATF4↝, 1,   CBP↓, 1,   ChrMod↑, 1,   cJun↓, 7,   cJun↑, 2,   cMyc↓, 35,   CREBBP↓, 1,   DLEU1↓, 1,   DNMT1↓, 6,   DNMT3A↓, 2,   DNMT3B↓, 2,   DNMTs↓, 5,   EZH2↓, 8,   FOXM1↓, 7,   FOXO↑, 1,   FOXO1↓, 3,   FOXO1↑, 3,   FOXO3↓, 2,   FOXO3↑, 2,   FOXO3↝, 1,   p‑FOXO3↓, 1,   FOXO4↓, 1,   FOXO4↑, 1,   H3↓, 1,   ac‑H3↑, 1,   H4↓, 1,   H4↑, 1,   ac‑H4↑, 1,   HATs↓, 3,   HATs↑, 1,   HDAC↓, 17,   HDAC∅, 1,   HDAC1↓, 3,   HDAC10↓, 1,   HDAC10↑, 1,   HDAC2↓, 3,   HDAC3↓, 2,   HDAC6↓, 2,   HDAC8↓, 1,   HES1↓, 1,   HMTs↓, 1,   JPT1/HN1↓, 1,   KLF2↓, 1,   KLF5↓, 1,   LINC01116↓, 1,   miR-107↑, 2,   miR-10b-5p↓, 1,   miR-124-3p↓, 1,   miR-126↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 3,   miR-155↓, 2,   miR-182-5p↓, 1,   miR-206↑, 1,   miR-21↓, 6,   miR-21↑, 1,   miR-224↓, 2,   miR-25-5p↓, 1,   miR-29b↓, 1,   miR-340↓, 2,   miR-34a↓, 2,   miR-34a↑, 5,   miR-375↑, 1,   miR-384↑, 1,   miR-422a↑, 2,   miR-429↑, 1,   miR-592↑, 1,   MTA2↓, 2,   Myc↓, 6,   OCT4↓, 11,   other↓, 5,   other↝, 5,   PhotoS↑, 1,   SOX2↓, 9,   SOX4↓, 4,   SOX4↑, 1,   SOX9↓, 1,   TCF-4↓, 2,   TFE3↑, 2,   tumCV?, 2,   tumCV↓, 59,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 23,   eIF2α↓, 3,   eIF2α↑, 4,   p‑eIF2α↑, 3,   ER Stress↓, 2,   ER Stress↑, 37,   Erlin1↑, 1,   ERStress↑, 1,   GRP78/BiP↓, 2,   GRP78/BiP↑, 12,   GRP94↑, 1,   HSF1↓, 2,   HSP27↓, 6,   HSP27↝, 1,   HSP70/HSPA5↓, 6,   HSP70/HSPA5↑, 3,   HSP70/HSPA5↝, 1,   HSP90↓, 11,   HSP90↑, 1,   IRE1↑, 4,   PERK↑, 6,   p‑PERK↑, 1,   Proteasome↓, 1,   UPR↑, 8,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 4,   ATG5↑, 10,   ATG7↑, 5,   Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 27,   p‑Beclin-1/ATG6↑, 1,   CTSK↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 7,   LC3A↑, 2,   LC3B↓, 1,   LC3B↑, 4,   LC3B-II↑, 7,   LC3I↓, 1,   LC3I↑, 1,   LC3II↑, 22,   LC3s↓, 1,   LC3s↑, 1,   lysoM↓, 1,   LysoPr↑, 1,   lysosome↓, 1,   MitoP↓, 1,   MitoP↑, 1,   p62↓, 18,   p62↑, 6,   PARK2↑, 3,   RUBCN↓, 1,   SESN2↑, 3,   TumAuto↓, 4,   TumAuto↑, 92,   TumAuto⇅, 1,   ULK1/ATG1↑, 2,   p‑ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM?, 1,   ATM↑, 1,   p‑ATM↑, 1,   p‑ATR↑, 1,   BRCA1↓, 2,   BRCA1↝, 1,   DFF45↓, 2,   DFF45↑, 1,   DNAdam↑, 45,   DNArepair↓, 2,   ERCC3↑, 1,   HR↓, 1,   hTERT/TERT↓, 4,   NBR2↑, 1,   p16↑, 3,   P53?, 1,   P53↓, 3,   P53↑, 74,   P53↝, 1,   p‑P53↑, 3,   p53 Wildtype↑, 1,   p53 Wildtype∅, 1,   p73↑, 1,   PARP↓, 3,   PARP↑, 22,   cl‑PARP↑, 55,   PARP1↑, 1,   cl‑PARP1↑, 1,   PCNA↓, 16,   POLD1↓, 1,   RAD51↓, 1,   SIRT6↑, 1,   Telomerase↓, 5,   TOP1?, 1,   TOP1↓, 5,   TOP2↓, 5,   TOP2↑, 1,   TP53↑, 1,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↑, 3,   γH2AX↝, 1,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 16,   CDK1↑, 3,   p‑CDK1↓, 1,   CDK2↓, 31,   CDK2↑, 2,   CDK4↓, 36,   CDK4↑, 3,   CDK4/6↓, 2,   CDK6↓, 15,   CDK6↑, 4,   CDKN1C/p57↓, 1,   CHK1↓, 1,   p‑CHK1↑, 2,   Chk2↓, 2,   p‑Chk2↑, 1,   ChrCon↑, 1,   Cyc↓, 1,   Cyc↝, 1,   cycA1/CCNA1↓, 11,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 25,   CycB/CCNB1↑, 5,   cycD1/CCND1↓, 58,   cycD1/CCND1↑, 2,   cycD1/CCND1↝, 1,   CycD3↓, 3,   cycE/CCNE↓, 18,   cycE1↓, 2,   E2Fs↓, 3,   E2Fs↑, 1,   Ki-67↓, 25,   mitA↓, 1,   mitA↑, 1,   p19↑, 2,   P21↓, 2,   P21↑, 53,   P21↝, 1,   p27/CDKN1B↓, 4,   p27/CDKN1B↑, 25,   pRB↓, 1,   p‑pRB↓, 1,   RB1↓, 1,   RB1↑, 1,   p‑RB1↓, 2,   Securin↓, 3,   TAp63α↑, 1,   TumCCA?, 2,   TumCCA↓, 5,   TumCCA↑, 153,   WEE1↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 4,   4E-BP1↑, 1,   p‑4E-BP1↓, 4,   ALDH↓, 5,   ALDH1A1↓, 1,   Axin2↑, 1,   BMI1↓, 2,   BMP7/OP1↓, 1,   BMPs↑, 2,   CD133↓, 6,   CD24↓, 3,   CD34↓, 2,   cFos↓, 9,   cFos↑, 1,   CSCs↓, 37,   CSCs↑, 1,   CSCsMark↓, 1,   Diff↑, 2,   EIF4E↓, 1,   FGF↓, 1,   Gli1↓, 12,   HH↓, 12,   IGF-1↓, 11,   IGFBP1↑, 3,   IGFBP3↓, 1,   IGFBP3↑, 1,   IGFBP7↑, 1,   JAG1↓, 1,   Jun↓, 1,   Ki-67↓, 25,   Let-7↓, 1,   Let-7↑, 2,   mTORC1↓, 9,   Nanog↓, 9,   Nestin↓, 1,   NOTCH↓, 18,   NOTCH↑, 1,   NOTCH1↓, 11,   NOTCH1↑, 2,   NOTCH2↑, 1,   NOTCH3↓, 2,   OGFr↑, 2,   p300↓, 1,   Piezo1↑, 1,   PTCH1↓, 3,   Shh↓, 7,   Smo↓, 7,   STAT1↓, 1,   Sufu↓, 1,   TumCG↓, 81,   TumCG↑, 4,   TumCP?, 2,   TumCP↓, 150,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt?, 1,   Wnt↓, 49,   Wnt↝, 1,   Wnt/(β-catenin)↓, 8,   Wnt/(β-catenin)↑, 1,  

Migration(tgid=13) ⓘ

AEG1↑, 1,   AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 11,   AP-1↝, 1,   AXL↓, 2,   CA↓, 2,   Ca+2↓, 4,   Ca+2↑, 25,   Ca+2↝, 1,   i-Ca+2?, 1,   CAFs/TAFs↓, 2,   Cal1↑, 1,   cal2↓, 1,   cal2↑, 1,   Cav1↓, 1,   CCN2/CTGF↓, 1,   Cdc42↓, 1,   Chl↓, 1,   Chl↑, 1,   Cofilin↓, 1,   COL1↓, 2,   COL3A1↓, 1,   DLC1↑, 1,   E-cadherin↓, 9,   E-cadherin↑, 44,   EMT↓, 71,   EMT↑, 2,   EMT↝, 1,   EpCAM↓, 1,   F-actin↓, 1,   F-actin↑, 1,   FAK↓, 11,   p‑FAK↓, 1,   Fibronectin↓, 5,   Furin↓, 1,   GIT1↓, 1,   GLI2↓, 5,   ITGA5↓, 1,   ITGB1↓, 1,   ITGB1↑, 1,   KRAS↓, 1,   LEF1↓, 1,   LIMK2↓, 1,   LRP1↓, 1,   MALAT1↓, 1,   MET↓, 5,   MET↑, 2,   p‑MET↓, 1,   MMP-10↓, 2,   MMP1↓, 4,   MMP13↓, 2,   MMP15↓, 1,   MMP16↓, 2,   MMP2↓, 77,   MMP2↑, 1,   MMP2↝, 1,   MMP3↓, 10,   MMP7↓, 10,   MMP9↓, 83,   MMP9↑, 2,   MMP9:TIMP1↓, 1,   MMPs↓, 26,   MTA1↓, 1,   MUC4↓, 2,   N-cadherin↓, 33,   NCAM↑, 1,   NEDD9↓, 1,   PAK1↓, 4,   PAK1↑, 1,   PDGF↓, 3,   Rac1↓, 2,   RECK↑, 1,   Rho↓, 3,   Rho↑, 1,   ROCK1↓, 7,   ROCK1↑, 1,   Sharpin↓, 1,   Slug↓, 11,   Smad1↓, 1,   SMAD2↓, 1,   SMAD2↑, 1,   p‑SMAD2↓, 1,   SMAD3↓, 2,   SMAD4↓, 2,   p‑SMAD4↓, 1,   Snail↓, 29,   talin↓, 1,   TET1↓, 1,   TET1↑, 2,   TGF-β↓, 18,   TGF-β↑, 2,   TIMP1↓, 2,   TIMP1↑, 4,   TIMP2↓, 3,   TIMP2↑, 3,   TSC1↑, 2,   TSP-1↑, 3,   TumCA↓, 3,   TumCI?, 2,   TumCI↓, 88,   TumCI↑, 1,   TumCMig?, 1,   TumCMig↓, 79,   TumCMig↑, 3,   TumMeta↓, 57,   TumMeta↑, 2,   TumPF↓, 1,   Twist↓, 20,   Tyro3↓, 1,   uPA↓, 19,   uPAR↓, 3,   Vim?, 1,   Vim↓, 38,   Vim↑, 1,   vinculin↓, 1,   Zeb1↓, 13,   ZEB2↓, 1,   α-tubulin↓, 1,   ac‑α-tubulin↑, 1,   β-catenin/ZEB1↓, 52,   β-catenin/ZEB1↑, 3,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 78,   angioG↑, 3,   CD31/PECAM-1↓, 5,   EGR4↓, 1,   Endoglin↑, 2,   eNOS↓, 1,   HIF-1↓, 9,   Hif1a↓, 63,   Hypoxia↓, 2,   LOX1↓, 1,   LymphAG↓, 1,   NO↓, 3,   NO↑, 1,   NO↝, 1,   VCAM-1↓, 4,   VEGF↓, 91,   VEGF↑, 1,   VEGF↝, 1,   VEGFR1↓, 5,   VEGFR2/KDR/Flk1↓, 15,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 2,   BBB↓, 1,   BBB↑, 3,   BBB∅, 2,   CellMemb↑, 1,   CLDN1↓, 3,   CLDN2↓, 1,   GLUT1↓, 22,   GLUT2↓, 1,   GLUT4↓, 2,   MMP↓, 86,   MMP↑, 2,   MPT↑, 2,   TRPM7↓, 2,   TRPM7↑, 1,   TRPV1↑, 2,   TRPV1↝, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↓, 1,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 2,   CD44↓, 14,   CD47↓, 1,   CD8+↑, 4,   cDC2↓, 1,   COX1↓, 2,   COX2/PTGS2↓, 57,   COX2/PTGS2↑, 3,   COX2/PTGS2↝, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCR4↓, 13,   DCells↑, 1,   DR4↑, 2,   FOXP3↑, 2,   HMGB1↓, 1,   ICAM-1↓, 7,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 5,   IL10↓, 8,   IL12↓, 2,   IL12↑, 1,   IL1α↓, 1,   IL1β↓, 12,   IL2↓, 1,   IL2↑, 5,   IL33↑, 1,   IL6↓, 34,   IL6↑, 1,   IL6↝, 1,   IL8↓, 5,   Imm↑, 10,   Imm↝, 3,   Inflam↓, 20,   IRAK1↓, 2,   pol-M1↑, 1,   M2 MC↓, 2,   MCP1/CCL2↓, 4,   MCT1↓, 2,   MDSCs↓, 1,   MIP2↓, 1,   mPGES-1↓, 1,   MyD88↑, 1,   NF-kB↓, 116,   NF-kB↑, 1,   NF-kB↝, 2,   p‑NF-kB↓, 1,   p‑NF-kB↑, 1,   NK cell↑, 2,   NLRP3↓, 4,   p50↓, 1,   p65↓, 4,   p‑p65↓, 3,   PD-1↓, 4,   PD-L1↓, 13,   PGE2↓, 16,   PSA↓, 9,   PSA↝, 1,   RAGE↓, 2,   SOCS-3↑, 1,   T-Cell↑, 1,   TCF↓, 2,   TCF↑, 1,   TCF↝, 1,   Th1 response↑, 2,   Th17↑, 1,   TLR2↓, 1,   TLR4↓, 5,   TLR4↑, 1,   TNF-α↓, 25,   TNF-α↑, 3,   TNF-α↝, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   TRADD↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GGT/CD224↑, 1,   pH↓, 1,   pH↑, 1,   e-pH↑, 1,   i-pH↓, 1,   TAMS↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   ADAM10↓, 1,   MAOA↓, 1,   PTN↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AhR↓, 1,   AhR↓, 2,   AR↓, 13,   AR↝, 1,   CYP19↓, 1,   ER-α36↓, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   PPARα↓, 1,   PPARα↑, 2,   PPARγ↓, 3,   PPARγ↑, 7,   RANKL↓, 1,   SXR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 33,   BioAv↑, 36,   BioAv↝, 9,   BioEnh↑, 2,   ChemoSen?, 1,   ChemoSen↑, 125,   CompStab↓, 3,   CompStab↑, 3,   CompStab↝, 3,   CYP1A1↓, 2,   CYP1A1↑, 1,   CYP1A2↓, 1,   CYP1B1↓, 1,   CYP1B1↑, 1,   CYP3A4↓, 1,   Dose?, 2,   Dose↑, 5,   Dose↝, 43,   Dose∅, 2,   eff?, 1,   eff↓, 32,   eff↑, 57,   eff↝, 8,   eff∅, 3,   GSTP1/GSTπ↓, 1,   GSTZ1↓, 1,   Half-Life↓, 11,   Half-Life↝, 12,   Half-Life∅, 1,   MDR1↓, 11,   MRP1/ABCC1↓, 2,   P-gp/ABCB1↓, 22,   P450↓, 2,   RadioS↑, 39,   selectivity↑, 58,   selectivity↝, 1,   Synergy?, 1,   Synergy↑, 83,   Synergy↝, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 1,   ALAT↓, 2,   ALP↓, 2,   AR↓, 13,   AR↝, 1,   AST↓, 1,   BG↓, 3,   BRCA1↓, 2,   BRCA1↝, 1,   CEA↓, 1,   CRP↓, 3,   E6↓, 3,   E7↓, 3,   EGFR↓, 47,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 1,   ERα/ESR1↓, 1,   EZH2↓, 8,   Ferritin↓, 3,   FOXM1↓, 7,   HemoG↓, 1,   HER2/EBBR2↓, 12,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 4,   IL6↓, 34,   IL6↑, 1,   IL6↝, 1,   KRAS↓, 1,   LDH↓, 8,   LDH↑, 3,   Myc↓, 6,   NOS2↓, 1,   NSE↓, 1,   PD-L1↓, 13,   PSA↓, 9,   PSA↝, 1,   RAGE↓, 2,   TP53↑, 1,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan?, 1,   AntiCan↑, 42,   antiD↑, 1,   antiNeop↑, 2,   AntiTum↓, 1,   AntiTum↑, 18,   Appetite↑, 1,   BowelM↑, 1,   breath↑, 1,   cachexia↓, 2,   cardioP↑, 9,   chemoP↑, 22,   chemoPv↑, 11,   ChemoSideEff↓, 3,   fatigue↓, 3,   hepatoP↑, 3,   Mucositis↓, 1,   neuroP↑, 5,   NP/CIPN↓, 1,   OS↑, 12,   OS⇅, 1,   OS∅, 1,   Pain↓, 3,   PFS↑, 1,   PFS∅, 1,   QoL↑, 6,   QoL∅, 1,   radioP↑, 6,   RenoP↑, 7,   Risk↓, 10,   Risk↑, 1,   Sleep↑, 2,   Strength↑, 2,   toxicity↓, 23,   toxicity↝, 10,   toxicity∅, 1,   TumVol↓, 20,   TumVol∅, 1,   TumW↓, 14,   TumW∅, 1,   Weight↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 2,   GutMicro↑, 8,   GutMicro↝, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 8,  
Total Targets: 1119

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 2,   antiOx↓, 4,   antiOx↑, 67,   mt-antiOx↑, 1,   ARE↑, 2,   Catalase↑, 38,   GPx↑, 24,   GPx1↑, 2,   GPx4↑, 2,   GSH↑, 22,   GSR↑, 3,   GSSG↓, 1,   GSTs↑, 8,   H2O2↓, 1,   HDL↓, 1,   HO-1?, 1,   HO-1↑, 23,   hyperG↓, 1,   hyperG↝, 1,   i-Iron↓, 1,   Keap1↓, 2,   Keap1↑, 1,   lipid-P↓, 22,   MDA↓, 23,   MDA↑, 1,   MPO↓, 2,   NOX4↓, 1,   NQO1↑, 7,   NRF2?, 1,   NRF2↑, 47,   RNS↓, 2,   ROS?, 1,   ROS↓, 87,   mt-ROS↓, 2,   SOD↓, 1,   SOD↑, 38,   SOD1↑, 2,   SOD2↑, 1,   TAC↑, 2,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↑, 1,   IronCh↓, 1,   IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compII↑, 1,   compIII↑, 1,   p‑DRP1/DNM1L↝, 1,   HSP60/HSPD1↓, 1,   Insulin↓, 4,   MFN1↝, 1,   MFN2↝, 1,   mtDam↓, 1,   OCR↑, 1,   PGC-1α↑, 5,   SIRT3↑, 3,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 2,   adiP↑, 1,   ALAT↓, 11,   AMPK↓, 1,   AMPK↑, 21,   AMPK↝, 1,   p‑AMPK↑, 1,   ATP↑, 5,   CRM↑, 1,   cytoP450↓, 1,   ECAR↓, 1,   FASN↓, 1,   glucose↓, 6,   glucose↝, 1,   GlucoseCon↑, 3,   glyC↓, 1,   Glycolysis↓, 1,   Glycolysis↑, 1,   GSK‐3β↓, 4,   GSK‐3β↑, 1,   H2S↑, 2,   HK2↑, 1,   LDL↓, 7,   NAD↑, 1,   NADPH↓, 4,   NADPH↑, 2,   PFK↑, 1,   PKM2↑, 1,   PLA2↓, 1,   SIRT1↑, 10,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 8,   Apoptosis↑, 1,   ASC↓, 1,   BAD↓, 1,   BAX↓, 7,   BAX↑, 1,   Bcl-2↓, 2,   Bcl-2↑, 4,   Casp↓, 1,   Casp1↓, 1,   Casp12↓, 2,   Casp3↓, 12,   Casp3↑, 1,   Casp3∅, 1,   cl‑Casp3↓, 2,   cl‑Casp8↓, 1,   Casp9↓, 2,   cl‑Casp9↓, 1,   Cyt‑c∅, 1,   Fas↓, 1,   FasL↓, 1,   Ferroptosis↓, 2,   GranB/GZMB↓, 1,   iNOS↓, 10,   p38↓, 2,   Pyro↓, 1,   TUNEL↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 8,   Akt↑, 18,   Akt↝, 1,   p‑Akt↓, 6,   p‑Akt↑, 3,   CREB↑, 1,   p‑CREB↑, 1,   ERK↓, 3,   ERK↑, 3,   p‑ERK↑, 2,   HGF/c-Met↑, 1,   IKKα↑, 1,   IκB?, 1,   JAK2↑, 1,   JNK↓, 2,   p‑JNK↓, 2,   p‑JNK↑, 1,   MAPK↓, 8,   MAPK↑, 1,   MAPK↝, 1,   mTOR↓, 26,   mTOR↑, 19,   mTOR↝, 2,   p‑mTOR↓, 10,   p‑mTOR↑, 3,   p‑p70S6↓, 1,   P70S6K↓, 3,   p‑P70S6K↑, 1,   PDGFR-BB↓, 1,   PDGFRB↓, 1,   PI3K↓, 6,   PI3K↑, 13,   PI3K↝, 1,   p‑PI3K↓, 2,   PKA↑, 1,   PKCδ↓, 1,   PTEN↓, 1,   PTP1B↓, 1,   RAS↓, 1,   RIP1↓, 1,   STAT3↓, 1,   STAT3↑, 2,   p‑STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 8,   ATF4↓, 1,   ATF4↑, 1,   cJun↓, 1,   p‑cMyc↑, 1,   FOXO3↑, 1,   HDAC2↓, 1,   HOTAIR↑, 1,   miR-107↑, 1,   other↓, 4,   other↑, 2,   other↝, 4,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 4,   p‑eIF2α↓, 1,   ER Stress↓, 4,   GRP78/BiP↓, 2,   HSP70/HSPA5↓, 1,   HSP90↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↓, 1,   Beclin-1/ATG6↓, 3,   Beclin-1/ATG6↑, 6,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3II↑, 4,   LC3s↓, 1,   MitoP↑, 2,   p62↓, 3,   p62↑, 1,   PARK2↑, 2,   TFEB↑, 1,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

p‑BRCA1↑, 1,   DNAdam↓, 3,   DNArepair↑, 1,   p16↓, 1,   P53↓, 2,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK5↓, 1,   P21↓, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   cFos↑, 1,   Diff↑, 1,   Diff↝, 1,   FGF↑, 1,   IGF-1↓, 1,   mTORC1↓, 1,   neuroG↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 8,   AP-1↓, 1,   Ca+2↓, 2,   Ca+2↑, 1,   Cartilage↑, 2,   COL1↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   MMP-10↓, 1,   MMP1↓, 1,   MMP13↓, 1,   MMP2↓, 1,   MMP3↓, 1,   MMP9↓, 2,   MMPs↑, 1,   N-cadherin↑, 1,   PAI-1/SERPINE1↓, 1,   PDGF↑, 1,   p‑Rac1↓, 1,   Rho↓, 1,   SMAD3↓, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 3,   TGF-β↑, 1,   TGF-β1↓, 1,   TIMP1↑, 1,   TIMP2↑, 1,   TregCell↑, 1,   TXNIP↓, 1,   Vim↓, 1,   α-SMA↓, 3,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 2,   CD31/PECAM-1↑, 1,   E-sel↓, 1,   eNOS↓, 1,   Hif1a↓, 2,   Hif1a↑, 1,   NO↓, 11,   NO↑, 1,   VEGF↓, 2,   VEGF↑, 3,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 2,   BBB↑, 9,   GastroP↑, 1,   GLUT4↑, 1,   IBI↑, 3,   MMP↑, 4,   MMP∅, 1,   MUC5AC↓, 1,   TRPA1↑, 1,   TRPC1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD4+↑, 1,   COX1↓, 1,   COX2/PTGS2↓, 18,   HMGB1↓, 2,   IFN-γ↓, 2,   IL1↓, 1,   IL1↑, 1,   IL10↓, 4,   IL10↑, 7,   IL17↓, 4,   IL18↓, 1,   IL1β↓, 24,   IL23↓, 2,   IL4↓, 2,   IL5↓, 1,   IL6↓, 30,   IL6↑, 1,   IL8↓, 6,   Imm↑, 5,   Inflam↓, 94,   Inflam↑, 1,   LPS↓, 2,   MCP1/CCL2↓, 2,   MyD88↓, 1,   NeuroI↓, 2,   NF-kB↓, 30,   p‑NF-kB↓, 1,   NLRP3↓, 10,   NLRP3↑, 1,   PGE2↓, 12,   PGE2↑, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR2↓, 2,   TLR4↓, 7,   TNF-α↓, 37,   TNF-α↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 2,   5HT↑, 2,   Ach↑, 4,   AChE↓, 14,   BChE↓, 1,   BDNF↑, 14,   ChAT↑, 2,   MAOA↓, 2,   NGF↑, 3,   TPH1↓, 1,   TrkB↑, 1,   TrkB↝, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 2,   Aβ↓, 20,   Aβ42↓, 1,   BACE/β-secretase↓, 7,   tau↓, 1,   p‑tau↓, 9,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

BNP↓, 1,   CYP19↓, 1,   FGF21↑, 1,   PPARα↑, 1,   PPARα↝, 1,   PPARγ↓, 3,   PPARγ↑, 2,   p‑PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 23,   BioAv↑, 18,   BioAv↝, 21,   BioEnh↑, 2,   CompStab↑, 2,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP2D6↓, 1,   Dose?, 2,   Dose↓, 1,   Dose↑, 1,   Dose↝, 12,   eff↑, 10,   eff↝, 1,   GSTA1↑, 1,   Half-Life↓, 3,   Half-Life↑, 1,   Half-Life↝, 12,   Half-Life∅, 2,   P-gp/ABCB1↓, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 11,   ALP↓, 4,   AST↓, 13,   BG↓, 1,   BloodF↑, 1,   BMD↑, 3,   BP↓, 2,   p‑BRCA1↑, 1,   BUN↓, 2,   colonLen↑, 1,   creat↓, 3,   CRP↓, 3,   IL6↓, 30,   IL6↑, 1,   LDH↓, 2,   Urea↓, 2,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 9,   antiAll↑, 11,   AntiArt↑, 6,   AntiCan↓, 1,   AntiCan↑, 14,   antiCG↑, 3,   antiD↓, 1,   AntiDiabetic↑, 13,   antiPs↑, 1,   AntiTum↑, 5,   cardioP↑, 31,   chemoP↑, 4,   chemoPv↑, 4,   cognitive↑, 23,   cough?, 1,   hepatoP↑, 31,   Learn↑, 3,   memory↑, 29,   motorD↑, 3,   Mucositis↓, 2,   neuroP?, 1,   neuroP↑, 67,   Obesity↓, 10,   OS↑, 4,   Pain↓, 1,   radioP↑, 3,   RenoP↑, 8,   Risk↓, 4,   SoreThr?, 1,   Strength↑, 3,   Stress↓, 1,   Stroke↓, 11,   toxicity↓, 23,   toxicity↑, 3,   toxicity↝, 10,   toxicity∅, 2,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 5,   AntiFungal↑, 5,   AntiP↑, 9,   AntiViral↑, 15,   Bacteria↓, 14,   Diar↓, 1,   GutMicro↑, 14,   Sepsis↓, 5,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 5,  
Total Targets: 403

Scientific Paper Hit Count for: mTOR, mammalian target of rapamycin
22 Curcumin
19 Fisetin
15 Quercetin
14 Berberine
13 Baicalein
11 Ivermectin
9 Thymoquinone
9 Magnetic Fields
9 Resveratrol
9 Sulforaphane (mainly Broccoli)
9 itraconazole
9 Luteolin
9 Matrine
8 Apigenin (mainly Parsley)
8 EGCG (Epigallocatechin Gallate)
8 Honokiol
8 Isoliquiritigenin
8 Shikonin
7 Alpha-Lipoic-Acid
7 Artemisinin
7 Metformin
6 Chemotherapy
6 diet FMD Fasting Mimicking Diet
6 Isorhamnetin
6 Lycopene
6 Magnolol
6 Melatonin
6 Urolithin
5 Capsaicin
5 Hydrogen Gas
5 Licochalcone A
5 Piperlongumine
5 Rosmarinic acid
5 Silymarin (Milk Thistle) silibinin
4 5-fluorouracil
4 Allyl isothiocyanate
4 Benzyl isothiocyanate
4 Phenethyl isothiocyanate
4 Ashwagandha(Withaferin A)
4 Beta-Caryophyllene
4 Chlorogenic acid
4 Chrysin
4 Cinnamon
4 Citric Acid
4 Dichloroacetate
4 Diindolylmethane
4 Gambogic Acid
4 Hyperoside
4 Isovitexin
4 Vitexin
4 Kaempferol
4 L-Theanine
4 Licorice
4 Magnetic Field Rotating
4 Morin
4 doxorubicin
4 Piperine
4 Pterostilbene
3 Coenzyme Q10
3 Astragalus
3 Cisplatin
3 Isothiocyanates
3 brusatol
3 Carnosic acid
3 salinomycin
3 diet Short Term Fasting
3 Eugenol
3 Ginkgolide B
3 HydroxyTyrosol
3 isoquercitrin
3 Mangiferin
3 Naringin
2 1,8-Cineole
2 Auranofin
2 Silver-NanoParticles
2 Allicin (mainly Garlic)
2 Anethole/trans-Anethole
2 Betulinic acid
2 Brucea javanica
2 Boswellia (frankincense)
2 Carvacrol
2 Thymol-Thymus vulgaris
2 Propolis -bee glue
2 Hydroxycinnamic-acid
2 Cranberry
2 Calorie Restriction Mimetics
2 Ursolic acid
2 CUSP9
2 Deguelin
2 Dandelion Root
2 Ellagic acid
2 Emodin
2 Ferulic acid
2 Formononetin
2 Garcinol
2 Ginkgetin
2 Juglone
2 Lasiodin
2 low dose naltrexone
2 MCT oil
2 Niclosamide (Niclocide)
2 Plumbagin
2 α-Santalol/Sandalwood oil
2 Vitamin D3
1 Andrographis
1 Fennel Oil/Foeniculum vulgare
1 2-DeoxyGlucose
1 Baicalin
1 Biochanin A
1 Bufalin/Huachansu
1 Beetroot
1 Butyrate
1 Trastuzumab
1 Celastrol
1 Centella asiatica / Gotu kola → asiaticoside
1 Cichoric acid / Chicoric acid
1 immunotherapy
1 Spermidine
1 Aspirin
1 Crocetin
1 Radiotherapy/Radiation
1 Chlorella (Chlorella vulgaris)
1 diet Methionine-Restricted Diet
1 Indole-3-carbinol
1 flavonoids
1 Fucoidan
1 Genistein (soy isoflavone)
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Ginseng
1 HydroxyCitric Acid
1 Huperzine A/Huperzia serrata
1 Inulin Prebiotic
1 phytic acid, Inositol hexakisphosphate
1 isoflavones
1 Sorafenib (brand name Nexavar)
1 Laetrile B17 Amygdalin
1 lambertianic acid
1 Lactoferrin/Talactoferrin
1 Linalool
1 Methylene blue
1 Mung Bean Sprouts
1 Magnesium
1 Moringa oleifera
1 Mushroom Chaga, Inonotus obliquus
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Nimbolide
1 Oleuropein
1 Oleocanthal
1 Marjoram (Origanum majorana)
1 Patchouli Oil (Pogostemon cablin)
1 sericin
1 Phycocyanin
1 Parthenolide
1 Gold NanoParticles
1 Selenium
1 Selenium NanoParticles
1 acetazolamide
1 Spirulina(Arthrospira/Limnospira)
1 Selenite (Sodium)
1 Terpenoids
1 Aflavin-3,3′-digallate
1 Usnic acid
1 Vitamin C (Ascorbic Acid)
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:209  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page